Key Acute Coronary Syndrome Market players Industry Trends, Segments, Analysis and Forecast – 2027
Acute Coronary Syndrome Market
The escalating stress levels have caused a sharp spike in the number of
cases detected in relation to heart diseases. Market reports connected with the
healthcare industry have been made accessible by Market Research Future who
publishes reports on other sectors that have been currently published along
with a report on this industry. Acute
Coronary Syndrome Market is projected to develop with a CAGR of 10.4% in the forecast
period.
Factors such as increased consumption of food that is saturated with
fat, smoking, alcohol consumption and increasing prevalence of sedentary
lifestyle are accredited with the rise in the cases of acute coronary syndrome
cases in the forecast period. Growing research and development in the market is
expected to reinforce the market expansion in the forecast period positively.
Major Key
Players:
The some of Key Acute Coronary Syndrome Market Players are Johnson & Johnson
Services, Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Boehringer
Ingelheim International GmbH (Germany), Portola Pharmaceuticals, Inc. (U.S.),
AbbVie Inc. (U.S.), Bayer AG (Germany), AstraZeneca (U.K), Eli Lilly and
Company (U.S.), Amgen Inc. (U.S.), Merck & Co., Inc. (U.S.),
GlaxoSmithKline Plc. (U.K), Daiichi Sankyo Company, Limited (Japan), Sanofi
(Paris), Novartis AG (Switzerland), and others.
Segment Analysis
The acute coronary syndrome market globally is
segmented on the basis of treatment, diagnosis, type, and end-user. On the
basis of end-user, the market is segmented into academic institutes, diagnostic
centers, hospitals and clinics, and others. By type, the market is segmented
into Non-ST-Elevation Myocardial Infarction (NSTEMI), ST-Elevation Myocardial
Infarction (STEMI), unstable angina, and others. By diagnosis, the market is
segmented into imaging, stress test, blood tests, and others. The imaging
segment is further sub-segmented into Computerized Tomography (CT) angiogram,
Myocardial Perfusion Imaging (MPI), coronary angiogram, echocardiogram, and
others. On the basis of pathophysiology of acute coronary syndrome
treatment is segmented into surgery, medication, and others. The medication
segment is sub-segmented into nitroglycerin, thrombolytics, antiplatelet drugs,
beta blockers, surgery, statins, and others. The antiplatelet drugs segment is
further segmented into clopidogrel, aspirin, prasugrel, and others. The beta
blockers segment is moreover segmented into nadolol, metoprolol, and others.
The statins segment is additionally segmented into simvastatin, atorvastatin,
and others. The surgery segment is sub-segmented into coronary bypass surgery,
angioplasty and stenting, and others.
Regional Analysis
The regional analysis of the
market states that the Americas dominates the global acute coronary syndrome
market owing to the rising prevalence of coronary heart diseases and the
presence of a well-developed healthcare sector within the region. Furthermore, growing
healthcare expenditure and the presence of market players within the region
boost the market. The European region comes in second in the acute coronary
syndrome market owing to the growing availability of funds for research, a
well-developed healthcare sector, and a huge patient population. The Asia
Pacific region is the fastest rising region for the market owing to the
incidence of emerging economies such as China, India, Australia, and others
within the region.
Furthermore, a vast patient
population, intensifying healthcare expenditure, and a quickly emerging
healthcare sector that will fuel the market development in the forecast period.
The Middle East and African region have the minimum share in the acute coronary
syndrome market. This can be accredited to the low per capita health care
spending and strict government policies, particularly within the African
region. Conversely, the Middle East holds a chunk of the market owing to huge
healthcare expenditure and a well-developed healthcare sector.
About Market Research
Future
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients. Our
market research studies by products, services, technologies, applications, end
users, and market players for global, regional, and country level market
segments, enable our clients to see more, know more, and do more, which help to
answer all their most important questions.
In order to stay updated with technology and work process
of the industry, MRFR often plans & conducts meet with the industry experts
and industrial visits for its research analyst members.
Contact us:
Market Research Future
(part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 646 845 9312
Comments
Post a Comment